Concepedia

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary E. Raskob, Nick van Es, Annelise Segers, Pantep Angchaisuksiri, Doyeun Oh, Z Boda, Roger M. Lyons, Karina Meijer, Ivan Gudz, Jeffrey I. Weitz,

The Lancet Haematology · 2016 · 155 citations · 26 references

Concepts

MedicineOncologyPharmacotherapyOncology PharmacotherapyAnticoagulant TherapyAnticoagulation TherapyAntithrombotic TherapyThromboembolic DiseaseThrombosisVenous ThromboembolismCancer-associated Deep Vein ThrombosisCancer-associated Thrombosis PreventionEdoxaban ToxicityThromboprophylaxis In Cancer PatientsThromboprophylaxis In Medical InpatientsVenous Thromboembolism Assessment

References

26

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis · 2005 · 4.9K citations

Medicine, Hematology, Pharmacology +12

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Joseph Ornelas et al. · CHEST Journal · 2016 · 4.8K citations

Medicine, Hematology, Pharmacotherapy +12

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2010 · 3.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12